Literature DB >> 29660947

Effects of Walkbot gait training on kinematics, kinetics, and clinical gait function in paraplegia and quadriplegia.

Jongseok Hwang1, Yongil Shin2, Ji-Ho Park1, Young Joo Cha1, Joshua Sung H You1.   

Abstract

BACKGROUND: The robotic-assisted gait training (RAGT) system has gained recognition as an innovative, effective paradigm to improve functional ambulation and activities of daily living in spinal cord injury and stroke. However, the effects of the Walkbot robotic-assisted gait training system with a specialized hip-knee-ankle actuator have never been examined in the paraplegia and quadriplegia population.
OBJECTIVE: The aim of this study was to determine the long-term effects of Walkbot training on clinical for hips and knee stiffness in individuals with paraplegia or quadriplegia.
METHODS: Nine adults with subacute or chronic paraplegia resulting from spinal cord injury or quadriplegia resulting from cerebral vascular accident (CVA) and/or hypoxia underwent progressive conventional gait retraining combined with the Walkbot RAGT for 5 days/week over an average of 43 sessions for 8 weeks. Clinical outcomes were measured with the Functional Ambulation Category (FAC), Modified Rankin Scale (MRS), Korean version of the Modified Barthel Index (K-MBI), Modified Ashworth Scale (MAS). Kinetic and kinematic data were collected via a built-in Walkbot program.
RESULTS: Wilcoxon signed-rank tests showed significant positive intervention effects on K-MBI, maximal hip flexion and extension, maximal knee flexion, active torque in the knee joint, resistive torque, and stiffness in the hip joint (P <  0.05). These findings suggest that the Walkbot RAGT was effective for improving knee and hip kinematics and the active knee joint moment while decreasing hip resistive force. These improvements were associated with functional recovery in gait, balance, mobility and daily activities.
CONCLUSIONS: These findings suggest that the Walkbot RAGT was effective for improving knee and hip kinematics and the active knee joint moment while decreasing hip resistive force. This is the first clinical evidence for intensive, long-term effects of the Walkbot RAGT on active or resistive moments and stiffness associated with spasticity and functional mobility in individuals with subacute or chronic paraplegia or quadriplegia who had reached a plateau in motor recovery after conventional therapy.

Entities:  

Keywords:  Paraplegia; Walkbot; gait; neurorehabilitation; quadriplegia; robotic-assisted gait training; stiffness

Mesh:

Year:  2018        PMID: 29660947     DOI: 10.3233/NRE-172226

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  5 in total

1.  Effects of Robotic Interactive Gait Training Combined with Virtual Reality and Augmented Reality on Balance, Gross Motor Function, Gait Kinetic, and Kinematic Characteristics in Angelman Syndrome: A Case Report.

Authors:  Sangkeun Han; Chanhee Park; Joshua Sung H You
Journal:  Children (Basel)       Date:  2022-04-12

Review 2.  A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review.

Authors:  Ram Gelman; Marc Berg; Yaron Ilan
Journal:  Int J Environ Res Public Health       Date:  2022-02-02       Impact factor: 3.390

3.  Stage 2: Who Are the Best Candidates for Robotic Gait Training Rehabilitation in Hemiparetic Stroke?

Authors:  Wonjun Oh; Chanhee Park; Seungjun Oh; Sung Joshua H You
Journal:  J Clin Med       Date:  2021-12-06       Impact factor: 4.241

4.  Optimal Intervention Timing for Robotic-Assisted Gait Training in Hemiplegic Stroke.

Authors:  Lingchao Xie; Bu Hyun Yoon; Chanhee Park; Joshua Sung H You
Journal:  Brain Sci       Date:  2022-08-10

5.  Effect of early integrated robot-assisted gait training on motor and balance in patients with acute ischemic stroke: a single-blinded randomized controlled trial.

Authors:  Guilin Meng; Xiaoye Ma; Pengfei Chen; Shaofang Xu; Mingliang Li; Yichen Zhao; Aiping Jin; Xueyuan Liu
Journal:  Ther Adv Neurol Disord       Date:  2022-09-15       Impact factor: 6.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.